These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 17646790)

  • 1. [Severe vitamin K deficiency during a drug wash-out procedure with cholestyramine].
    Chalumeau S; Chaulier K; Ber CE; Rimmelé T
    Gastroenterol Clin Biol; 2007; 31(6-7):614-5. PubMed ID: 17646790
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful treatment of leflunomide-induced acute pneumonitis with cholestyramine wash-out therapy.
    Wong SP; Chu CM; Kan CH; Tsui HS; Ng WL
    J Clin Rheumatol; 2009 Dec; 15(8):389-92. PubMed ID: 19955995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leflunomide-induced acute hepatitis.
    Sevilla-Mantilla C; Ortega L; Agúndez JA; Fernández-Gutiérrez B; Ladero JM; Díaz-Rubio M
    Dig Liver Dis; 2004 Jan; 36(1):82-4. PubMed ID: 14971821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe hepatotoxicity in a rheumatoid arthritis patient switched from leflunomide to methotrexate.
    Gupta R; Gupta SK
    MedGenMed; 2005 Sep; 7(3):9. PubMed ID: 16369235
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of a Cholestyramine Washout in a Patient With Septic Shock on Leflunomide Therapy: A Case Report and Review of the Literature.
    Laub M; Fraser R; Kurche J; Lara A; Kiser TH; Reynolds PM
    J Intensive Care Med; 2016 Jul; 31(6):412-4. PubMed ID: 26446104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin K deficiency and bleeding after long-term use of cholestyramine.
    Vroonhof K; van Rijn HJ; van Hattum J
    Neth J Med; 2003 Jan; 61(1):19-21. PubMed ID: 12688565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leflunomide-related acute interstitial pneumonia in two patients with rheumatoid arthritis: autopsy findings with a mosaic pattern of acute and organizing diffuse alveolar damage.
    Ochi S; Harigai M; Mizoguchi F; Iwai H; Hagiyama H; Oka T; Miyasaka N
    Mod Rheumatol; 2006; 16(5):316-20. PubMed ID: 17039315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propofol-induced acute toxic hepatitis after brief sedation for endoscopic retrograde cholangiopancreatography.
    Polo-Romero FJ; Paricio P; Tovar A; Alonso JM
    Endoscopy; 2008 Sep; 40 Suppl 2():E49. PubMed ID: 18300198
    [No Abstract]   [Full Text] [Related]  

  • 9. Leflunomide for the treatment of rheumatoid arthritis in clinical practice: incidence and severity of hepatotoxicity.
    van Roon EN; Jansen TL; Houtman NM; Spoelstra P; Brouwers JR
    Drug Saf; 2004; 27(5):345-52. PubMed ID: 15061688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leflunomide-induced toxic epidermal necrolysis in a patient with rheumatoid arthritis.
    Hassikou H; El Haouri M; Tabache F; Baaj M; Safi S; Hadri L
    Joint Bone Spine; 2008 Oct; 75(5):597-9. PubMed ID: 18805724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leflunomide induced acute interstitial pneumonia.
    Takeishi M; Akiyama Y; Akiba H; Adachi D; Hirano M; Mimura T
    J Rheumatol; 2005 Jun; 32(6):1160-3. PubMed ID: 15940779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe hypertriglygeridemia in a rheumatoid arthritis patient treated with leflunomide.
    Spanakis EK; Katsikas GA; Sidiropoulos PI; Kritikos HD
    Clin Exp Rheumatol; 2008; 26(2):382. PubMed ID: 18565269
    [No Abstract]   [Full Text] [Related]  

  • 13. Leflunomide induced fevers, thrombocytosis, and leukocytosis in a patient with relapsing polychondritis.
    Koenig AS; Abruzzo JL
    J Rheumatol; 2002 Jan; 29(1):192-4. PubMed ID: 11824960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe leukopenia in a rheumatoid arthritis patient treated with a methotrexate/leflunomide combination.
    Toth P; Bernd R
    Rev Bras Reumatol; 2014; 54(2):152-4. PubMed ID: 24878863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leflunomide for relapsing polychondritis: successful longterm treatment.
    Handler RP
    J Rheumatol; 2006 Sep; 33(9):1916; author reply 1916-7. PubMed ID: 16960961
    [No Abstract]   [Full Text] [Related]  

  • 16. Newer disease-modifying antirheumatic drugs and the risk of serious hepatic adverse events in patients with rheumatoid arthritis.
    Suissa S; Ernst P; Hudson M; Bitton A; Kezouh A
    Am J Med; 2004 Jul; 117(2):87-92. PubMed ID: 15234643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute hepatitis associated to leflunomide in a patient with rheumatoid arthritis.
    Chávez-López MA; Ramírez-González A; Martínez-Guevara MA
    Gastroenterol Hepatol; 2007; 30(7):430. PubMed ID: 17692207
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful treatment of a leg ulcer occurring in a rheumatoid arthritis patient under leflunomide therapy.
    Knab J; Goos M; Dissemond J
    J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):243-6. PubMed ID: 15752303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Toxic liver injury].
    Bode C; Martini GA
    Med Klin; 1970 Jan; 65(1):8-16. PubMed ID: 4926626
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk of hepatotoxicity with add-on leflunomide in rheumatoid arthritis patients.
    Gupta R; Bhatia J; Gupta SK
    Arzneimittelforschung; 2011; 61(5):312-6. PubMed ID: 21755815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.